Myopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Myopia occurs when the focused image is too close to the eye's retinal photoreceptor layer. Myopia is classified into two types. The simple, less severe conditions are also known as physiological or school myopia, and they occur as a result of the correlative failure of the normal eye's refractive components. It can also be caused by an increase in the curvature of the surface of the cornea or lens and an increase in the axial diameter of the eye. Myopia of up to – 6.0 D is involved. Pathological, degenerative, malignant, or high myopia is a rare form that causes progressive elongation of the globe and accompanying stretching of the scleral wall, resulting in a high refractive error of – 6 D or higher. High myopia frequently causes choroid atrophy and subsequent retinal macular degeneration, resulting in loss of central visual acuity and an increased risk of retinal detachment, glaucoma, and strabismus. High myopia is a significant cause of legal blindness in many developed countries. However, genetic and environmental factors that have been implicated in the etiology of myopia remain to be known.
·
The prevalence of patient pool of myopia
varies from 90 MN to 100 MN in the USA, with a male and female ratio of 46% and
54%.
Thelansis’s
“Myopia Market Outlook, Epidemiology, Competitive Landscape, and Market
Forecast Report – 2023 To 2033" covers disease overview, epidemiology,
drug utilization, prescription share analysis, competitive landscape, clinical
practice, regulatory landscape, patient share, market uptake, market forecast,
and key market insights under the potential Myopia treatment modalities options
for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and
China).
KOLs insights of Myopia across 8 MM
market from the centre of Excellence/ Public/ Private hospitals participated in
the study. Insights around current treatment landscape, epidemiology, clinical
characteristics, future treatment paradigm, and Unmet needs.
Myopia
Market Forecast Patient Based Forecast Model (MS. Excel Based Automated
Dashboard), which Data Inputs with sourcing, Market Event, and Product Event,
Country specific Forecast Model, Market uptake and patient share uptake,
Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario,
Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Tags: Myopia, Myopia
market outlook, Myopia competitive landscape, Myopia market
forecast, Thelansis, Primary market research, KOL insights, Competitive
Intelligence (CI)
Comments
Post a Comment